Logo image of BW

BABCOCK & WILCOX ENTERPR (BW) Stock Fundamental Analysis

NYSE:BW - New York Stock Exchange, Inc. - US05614L2097 - Common Stock - Currency: USD

0.4642  +0 (+0.76%)

After market: 0.4642 0 (0%)

Fundamental Rating

2

Overall BW gets a fundamental rating of 2 out of 10. We evaluated BW against 97 industry peers in the Electrical Equipment industry. BW has a bad profitability rating. Also its financial health evaluation is rather negative. BW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BW has reported negative net income.
BW had a negative operating cash flow in the past year.
In the past 5 years BW reported 4 times negative net income.
In the past 5 years BW always reported negative operating cash flow.
BW Yearly Net Income VS EBIT VS OCF VS FCFBW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -10.29%, BW perfoms like the industry average, outperforming 59.79% of the companies in the same industry.
The Return On Invested Capital of BW (6.94%) is better than 80.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BW is significantly below the industry average of 9.63%.
The last Return On Invested Capital (6.94%) for BW is above the 3 year average (3.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -10.29%
ROE N/A
ROIC 6.94%
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
BW Yearly ROA, ROE, ROICBW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

BW has a Operating Margin of 4.15%. This is in the better half of the industry: BW outperforms 72.16% of its industry peers.
BW's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 24.68%, BW perfoms like the industry average, outperforming 55.67% of the companies in the same industry.
BW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.15%
PM (TTM) N/A
GM 24.68%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
BW Yearly Profit, Operating, Gross MarginsBW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BW has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BW has been increased compared to 1 year ago.
The number of shares outstanding for BW has been increased compared to 5 years ago.
BW has a worse debt/assets ratio than last year.
BW Yearly Shares OutstandingBW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BW Yearly Total Debt VS Total AssetsBW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BW has an Altman-Z score of -1.85. This is a bad value and indicates that BW is not financially healthy and even has some risk of bankruptcy.
BW has a worse Altman-Z score (-1.85) than 67.01% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.85
ROIC/WACC1.04
WACC6.68%
BW Yearly LT Debt VS Equity VS FCFBW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

BW has a Current Ratio of 1.26. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, BW is not doing good in the industry: 67.01% of the companies in the same industry are doing better.
A Quick Ratio of 0.98 indicates that BW may have some problems paying its short term obligations.
BW's Quick ratio of 0.98 is in line compared to the rest of the industry. BW outperforms 43.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
BW Yearly Current Assets VS Current LiabilitesBW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

BW shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.61%.
BW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.29%.
The Revenue has been decreasing by -3.54% on average over the past years.
EPS 1Y (TTM)2.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.08%
Revenue 1Y (TTM)-30.29%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-11.62%

3.2 Future

BW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.43% yearly.
Based on estimates for the next years, BW will show a decrease in Revenue. The Revenue will decrease by -1.60% on average per year.
EPS Next Y86.66%
EPS Next 2Y43.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.47%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BW Yearly Revenue VS EstimatesBW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
BW Yearly EPS VS EstimatesBW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BW. In the last year negative earnings were reported.
Also next year BW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BW Price Earnings VS Forward Price EarningsBW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BW is valued cheaply inside the industry as 81.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.32
BW Per share dataBW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

BW's earnings are expected to grow with 43.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.43%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BABCOCK & WILCOX ENTERPR

NYSE:BW (5/2/2025, 4:02:05 PM)

After market: 0.4642 0 (0%)

0.4642

+0 (+0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners75.24%
Inst Owner Change-0.12%
Ins Owners3.59%
Ins Owner Change-0.45%
Market Cap45.68M
Analysts82
Price Target2.38 (412.71%)
Short Float %4.34%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-24.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2165.17%
Min EPS beat(2)-4779.86%
Max EPS beat(2)449.52%
EPS beat(4)1
Avg EPS beat(4)-2045.34%
Min EPS beat(4)-4779.86%
Max EPS beat(4)449.52%
EPS beat(8)1
Avg EPS beat(8)-1327.75%
EPS beat(12)1
Avg EPS beat(12)-927.28%
EPS beat(16)5
Avg EPS beat(16)-646.93%
Revenue beat(2)0
Avg Revenue beat(2)-9.9%
Min Revenue beat(2)-11.29%
Max Revenue beat(2)-8.5%
Revenue beat(4)0
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-11.29%
Max Revenue beat(4)-2.5%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)5
Avg Revenue beat(12)-1%
Revenue beat(16)7
Avg Revenue beat(16)0.24%
PT rev (1m)-48.15%
PT rev (3m)-49.55%
EPS NQ rev (1m)-21.21%
EPS NQ rev (3m)-26.98%
EPS NY rev (1m)-250%
EPS NY rev (3m)-2700%
Revenue NQ rev (1m)-4.32%
Revenue NQ rev (3m)-4.32%
Revenue NY rev (1m)-7.38%
Revenue NY rev (3m)-9.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.32
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.21
OCFYN/A
SpS7.29
BVpS-2.88
TBVpS-3.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.29%
ROE N/A
ROCE 8.79%
ROIC 6.94%
ROICexc 7.46%
ROICexgc 10.99%
OM 4.15%
PM (TTM) N/A
GM 24.68%
FCFM N/A
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
ROICexc(3y)4.08%
ROICexc(5y)4.44%
ROICexgc(3y)6%
ROICexgc(5y)6.49%
ROCE(3y)4.64%
ROCE(5y)4.69%
ROICexcg growth 3Y18.44%
ROICexcg growth 5Y33.31%
ROICexc growth 3Y21.33%
ROICexc growth 5Y31.59%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
F-Score2
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 8.12
Cap/Depr 67.06%
Cap/Sales 1.56%
Interest Coverage 0.8
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z -1.85
F-Score2
WACC6.68%
ROIC/WACC1.04
Cap/Depr(3y)56.25%
Cap/Depr(5y)50.83%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.08%
EPS Next Y86.66%
EPS Next 2Y43.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.29%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-11.62%
Revenue Next Year-12.47%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.97%
EBIT growth 3Y8.96%
EBIT growth 5Y36.41%
EBIT Next Year29.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-149.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180.9%
OCF growth 3YN/A
OCF growth 5YN/A